Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Massachusetts General Hospital
Dana-Farber Cancer Institute
Ruijin Hospital
University of Miami
M.D. Anderson Cancer Center
Northwestern University
Fred Hutchinson Cancer Center